Stockholm's innovative life sciences region has attracted yet another international player, this time the Dutch consultant Jibin Chi and his company, Channel Biomedix.

Channel Biomedix specialises in bringing innovative technologies and products to the biomedical and life science field. Chi said the high level of intellectual property and the large pool of talent in the Swedish capital is what attracted him.

"If we talk about the biomedical and life science sector, Sweden is considered one of the most innovative countries in the world," he told The Swedish Wire.

"Another interesting and important aspect about Sweden is how effectively they are able to convert research into clinical application. The so-called bench to bedside or translational research is largely realised in what is a small country."

However, Chi added that Swedes are not very familiar with the market outside of Scandinavia, particularly the Asia Pacific market. And that's where he expects his company to make its mark.

"Swedes seem to be too modest to effectively sell themselves. So their expertise on the commercial side is, in my opinion, an area to be developed," he said.

In the current gloomy economic climate, it's getting more and more important for Swedish and European companies to take advantage of developing markets.

"Going international and going to Asia should be the first step rather than the last step," Chi explained.

Chi described Channel Biomedix's objective as trying to facilitate the perfusion of innovative technologies around the international market.

"Because of the many opportunities we see, we have set up a branch in Stockholm so that we are at the immediate source of innovation," he said.

"Next to this we are going to set up another company in Asia. By doing that, we can truly function as the bridge between innovation and market."

- - -

This article was published in collaboration with Stockholm Business Region.

More news about Stockholm?
Subscribe to Invest in Stockholm Newsletter today.